新型冠状病毒肺炎患者进行肺康复的益处。
The benefits of pulmonary rehabilitation in patients with COVID-19.
作者信息
He Zhen-Feng, Zhong Nan-Shan, Guan Wei-Jie
机构信息
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
Both authors contributed equally to the work.
出版信息
ERJ Open Res. 2021 May 31;7(2). doi: 10.1183/23120541.00212-2021. eCollection 2021 Apr.
相似文献
1
The benefits of pulmonary rehabilitation in patients with COVID-19.
ERJ Open Res. 2021 May 31;7(2). doi: 10.1183/23120541.00212-2021. eCollection 2021 Apr.
2
Balloon pulmonary angioplasty: are we there yet? Lessons learned and unanswered questions.
Breathe (Sheff). 2022 Dec;18(4):220217. doi: 10.1183/20734735.0217-2022. Epub 2023 Jan 10.
3
Providing answers to respiratory patients' questions during COVID-19.
Breathe (Sheff). 2020 Sep;16(3):200219. doi: 10.1183/20734735.0219-2020.
4
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey.
ERJ Open Res. 2020 Nov 2;6(4). doi: 10.1183/23120541.00520-2020. eCollection 2020 Oct.
5
Impact of COVID-19 shielding on physical activity and quality of life in patients with COPD.
Breathe (Sheff). 2020 Sep;16(3):200231. doi: 10.1183/20734735.0231-2020.
6
Puzzling persisting symptoms after COVID-19.
ERJ Open Res. 2022 Apr 19;8(2). doi: 10.1183/23120541.00709-2021. eCollection 2022 Apr.
7
Challenges in pulmonary rehabilitation: COVID-19 and beyond.
Pol Arch Intern Med. 2022 Nov 25;132(11). doi: 10.20452/pamw.16357. Epub 2022 Oct 14.
8
COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society.
ERJ Open Res. 2021 Oct 25;7(4). doi: 10.1183/23120541.00402-2021. eCollection 2021 Oct.
9
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset.
ERJ Open Res. 2021 Oct 11;7(4). doi: 10.1183/23120541.00431-2021. eCollection 2021 Oct.
10
COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity.
ERJ Open Res. 2021 Jul 19;7(3). doi: 10.1183/23120541.00196-2021. eCollection 2021 Jul.
引用本文的文献
1
Safety and Efficacy of Incentive Spirometer in Covid-19 Pneumonia; a Randomized Clinical Trial.
Arch Acad Emerg Med. 2024 May 18;12(1):e51. doi: 10.22037/aaem.v12i1.2244. eCollection 2024.
2
[Respiratory physiotherapy in post-COVID-19: a decision-making algorithm for clinical practice].
Open Respir Arch. 2021 Oct 12;4(1):100139. doi: 10.1016/j.opresp.2021.100139. eCollection 2022 Jan-Mar.
3
Research progress of post-acute sequelae after SARS-CoV-2 infection.
Cell Death Dis. 2024 Apr 11;15(4):257. doi: 10.1038/s41419-024-06642-5.
4
Impact of respiratory muscle training on clinical and functional parameters in COVID-19 recovered patients.
Pan Afr Med J. 2023 Oct 19;46:65. doi: 10.11604/pamj.2023.46.65.36615. eCollection 2023.
5
Post-COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration.
J Clin Pathw. 2023;9(1):22-28. doi: 10.25270/jcp.2023.01.02.
本文引用的文献
1
Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study.
ERJ Open Res. 2021 May 31;7(2). doi: 10.1183/23120541.00108-2021. eCollection 2021 Apr.
2
Outcomes of a COVID-19 recovery program for patients hospitalized with SARS-CoV-2 infection in New York City: A prospective cohort study.
PM R. 2021 Jun;13(6):609-617. doi: 10.1002/pmrj.12578. Epub 2021 Mar 22.
3
Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU.
Respir Physiol Neurobiol. 2021 May;287:103639. doi: 10.1016/j.resp.2021.103639. Epub 2021 Feb 12.
4
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
5
Distinct phenotypes in COVID-19 may require distinct pulmonary rehabilitation strategies.
Monaldi Arch Chest Dis. 2020 Dec 3;90(4). doi: 10.4081/monaldi.2020.1523.
6
Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae.
Respir Med. 2020 Nov-Dec;174:106197. doi: 10.1016/j.rmed.2020.106197. Epub 2020 Oct 20.
7
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.
Clin Microbiol Infect. 2021 Jan;27(1):89-95. doi: 10.1016/j.cmi.2020.09.023. Epub 2020 Sep 23.
8
Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach.
Respirology. 2020 Dec;25(12):1320-1322. doi: 10.1111/resp.13946. Epub 2020 Sep 21.
9
COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force.
Eur Respir J. 2020 Dec 3;56(6). doi: 10.1183/13993003.02197-2020. Print 2020 Dec.
10
Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19.
Am J Phys Med Rehabil. 2020 Oct;99(10):865-869. doi: 10.1097/PHM.0000000000001549.
Zotero 插件